AGP Picks
View all

European News Update
Provided by AGP

European News Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European News Update.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on June 4, 2026

RenovoRx CEO, Shaun Bagai, to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23rd
Jun. 4, 2026

RenovoRx CEO, Shaun Bagai, to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23rd

Indeterminate GlobeNewswire
Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
Jun. 4, 2026

Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

Indeterminate GlobeNewswire
Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting
Jun. 4, 2026

Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting

Indeterminate GlobeNewswire
GoldHaven Advances Copeçal Toward Q3 Drilling; Identifies Priority Eastern Targets
Jun. 4, 2026

GoldHaven Advances Copeçal Toward Q3 Drilling; Identifies Priority Eastern Targets

Indeterminate GlobeNewswire
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies
Jun. 4, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies

Indeterminate GlobeNewswire
Tribeca Enterprises CEO Rebecca Glashow and Two-Time NBA Champion Kenny Smith to Speak at Jupiter Festival Miami
Jun. 4, 2026

Tribeca Enterprises CEO Rebecca Glashow and Two-Time NBA Champion Kenny Smith to Speak at Jupiter Festival Miami

Indeterminate GlobeNewswire
Fusion Fuel Highlights Jaguar Uranium’s Surface Uranium-Copper-Vanadium Findings at Huemul Project; Planned Royal Uranium Acquisition Expected to Provide 1.0% NSR Royalty Exposure
Jun. 4, 2026

Fusion Fuel Highlights Jaguar Uranium’s Surface Uranium-Copper-Vanadium Findings at Huemul Project; Planned Royal Uranium Acquisition Expected to Provide 1.0% NSR Royalty Exposure

Indeterminate GlobeNewswire
Octave Intelligence plc Form 10-Q for the Quarterly Period Ended March 31, 2026
Jun. 4, 2026

Octave Intelligence plc Form 10-Q for the Quarterly Period Ended March 31, 2026

Indeterminate GlobeNewswire
BTC/USD Slides 13% in a Week; AIX Alpha Launches the “Smart Bitcoin Challenge”
Jun. 4, 2026

BTC/USD Slides 13% in a Week; AIX Alpha Launches the “Smart Bitcoin Challenge”

Indeterminate GlobeNewswire
Hydroquinone Market Projected to Grow to US$ 739.8 Million by 2033, Expanding at a CAGR of 4.8% from 2026 to 2033
Jun. 4, 2026

Hydroquinone Market Projected to Grow to US$ 739.8 Million by 2033, Expanding at a CAGR of 4.8% from 2026 to 2033

Indeterminate EIN Presswire
My Talking Tom 2 Reworks Its Backyard Into a Playable World
Jun. 4, 2026

My Talking Tom 2 Reworks Its Backyard Into a Playable World

Indeterminate GlobeNewswire
Sustainability LIVE unveils first 2026 London Summit panel: The Future of Net Zero Automotive
Jun. 4, 2026

Sustainability LIVE unveils first 2026 London Summit panel: The Future of Net Zero Automotive

Indeterminate GlobeNewswire
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Jun. 4, 2026

Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution

Indeterminate GlobeNewswire
Aya Gold & Silver Releases its 2025 Sustainability Report
Jun. 4, 2026

Aya Gold & Silver Releases its 2025 Sustainability Report

Indeterminate GlobeNewswire
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
Jun. 4, 2026

Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease

Indeterminate GlobeNewswire
Onco360® Has Been Selected as a National Specialty Pharmacy Provider for JYLAMVO® (methotrexate) Oral Solution
Jun. 4, 2026

Onco360® Has Been Selected as a National Specialty Pharmacy Provider for JYLAMVO® (methotrexate) Oral Solution

Indeterminate GlobeNewswire
OT Group Ltd Provides Monthly Market Update and Private Equity Outlook
Jun. 4, 2026

OT Group Ltd Provides Monthly Market Update and Private Equity Outlook

Indeterminate GlobeNewswire
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society
Jun. 4, 2026

AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society

Indeterminate GlobeNewswire
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026
Jun. 4, 2026

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026

Indeterminate GlobeNewswire
Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial
Jun. 4, 2026

Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

European News Update

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.